Alternative Isoforms as Molecular Modulators of Cellular Senescence in Cancer
- 1Departamento de Bioquímica Vegetal y Biología Molecular, Universidad de Sevilla, 41012 Sevilla, Spain
- 2Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío (HUVR), Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, 41013 Sevilla, Spain
- 3CIBER de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain
Abstract
Cellular senescence is a stress-induced, stable proliferative arrest that acts as a potent barrier to tumorigenesis, yet the senescence-associated secretory phenotype that accompanies it can paradoxically fuel inflammation, angiogenesis and the phenotypic plasticity contributing to tumor heterogeneity, therapy resistance and cancer stem cell emergence. A largely unexplored molecular layer in the senescence program is alternative pre-mRNA splicing, which generates protein isoforms with functionally divergent effects on cell-cycle arrest, apoptosis and the secretory program. More than 90% of human multi-exon genes are alternatively spliced, so most of the nearly 1000 genes linked to senescence are expected to produce several isoforms, yet fewer than twenty have been examined at this level, and direct evidence is available for only about half of these. We review how alternative splicing, together with related mechanisms such as alternative promoter usage and alternative reading-frame selection, modulates distinct outputs of the senescence program, including commitment, persistence, escape and SASP composition, across gene groups such as the TP53/TP63/TP73 family, MDM2/MDM4 and the androgen receptor locus. This evidence ranges from direct causal manipulation to correlative or mechanistically adjacent findings, classified explicitly by evidence level. Direct causal evidence remains limited, making isoform-resolved functional validation a major unmet need in the field.
Related
- Cellular Senescence in Ocular Surface Diseases: Molecular Mechanisms and Therapeutic Perspectives
- Identification and analysis of obesity-cellular senescence associated key genes in metabolic syndrome based on transcriptomic data
- Cellular senescence changes and their association with brain structure in schizophrenia and major depressive disorder
- Macrophage senescence and senescence-like states in senile osteoporosis: cellular cross-talk and therapeutic perspectives
- Methylation-associated Gene Expression (MaGE): a non-invasive, in vivo measure of cellular senescence.
BibTeX
@article{garciaheredia2026alternative,
title = {{Alternative Isoforms as Molecular Modulators of Cellular Senescence in Cancer}},
author = {José Manuel García-Heredia},
journal = {Cancers},
year = {2026},
month = oct,
doi = {10.3390/cancers18203301},
url = {https://www.mdpi.com/2072-6694/18/20/3301},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Alternative Isoforms as Molecular Modulators of Cellular Senescence in Cancer
AU - José Manuel García-Heredia
PY - 2026
DA - 2026/10/01
JO - Cancers
DO - 10.3390/cancers18203301
UR - https://www.mdpi.com/2072-6694/18/20/3301
AB - Cellular senescence is a stress-induced, stable proliferative arrest that acts as a potent barrier to tumorigenesis, yet the senescence-associated secretory phenotype that accompanies it can paradoxically fuel inflammation, angiogenesis and the phenotypic plasticity contributing to tumor heterogeneity, therapy resistance and cancer stem cell emergence. A largely unexplored molecular layer in the senescence program is alternative pre-mRNA splicing, which generates protein isoforms with functionally divergent effects on cell-cycle arrest, apoptosis and the secretory program. More than 90% of human multi-exon genes are alternatively spliced, so most of the nearly 1000 genes linked to senescence are expected to produce several isoforms, yet fewer than twenty have been examined at this level, and direct evidence is available for only about half of these. We review how alternative splicing, together with related mechanisms such as alternative promoter usage and alternative reading-frame selection, modulates distinct outputs of the senescence program, including commitment, persistence, escape and SASP composition, across gene groups such as the TP53/TP63/TP73 family, MDM2/MDM4 and the androgen receptor locus. This evidence ranges from direct causal manipulation to correlative or mechanistically adjacent findings, classified explicitly by evidence level. Direct causal evidence remains limited, making isoform-resolved functional validation a major unmet need in the field.
SN - 2072-6694
ER -